Completed
Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.
NCT00150293
- Conditions
- Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +3 more
- Locations
-
- Pfizer Investigational Site Deakin, Australian Capital Territory, Australia
- Pfizer Investigational Site Camperdown, New South Wales, Australia
- Pfizer Investigational Site Chastwood, New South Wales, Australia
- Pfizer Investigational Site Cairns, Queensland, Australia